ReviewAdvances in therapy2019
Recognising Lung Cancer in Primary Care.
Review in Advances in therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05227261 (Assessment of a Novel Blood Test in Early Detection of the Five Common Cancers Based on the Investigation of the Circulating Tumour DNA), which is not on this map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessment of a Novel Blood Test in Early Detection of the Five Common Cancers Based on the Investigation of the Circulating Tumour DNA
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.
- [Cancer prevention recommendations: Update 2024].Atencion primaria · 2024Guideline
- A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms.NPJ primary care respiratory medicine · 2022Pooled it
- Screening and identification of biomarkers in tumor-educated platelets for non-small cell lung cancer.BMC cancer · 2026Article
- Can general practitioners use smoking status data in electronic health records to recruit patients for lung cancer screening? A descriptive study using the MedicineInsight database.BMC primary care · 2026Article
- Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancer.Communications medicine · 2026Article
- Changes in diagnostic evaluation of patients with lung cancer symptoms.NPJ primary care respiratory medicine · 2025Article
- Physician distribution and income-inequality on lung cancer mortality in Brazil.BMC research notes · 2025Article
- Mapping intellectual structure and research hotspots of cancer studies in primary health care: A machine-learning-based analysis.Medicine · 2025Article
- The Promise of Infrared Spectroscopy in Liquid Biopsies for Solid Cancer Detection.Diagnostics (Basel, Switzerland) · 2025Review
- Exploring the oncogenic role and prognostic value ofFrontiers in genetics · 2025Article
- Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review.Current oncology (Toronto, Ont.) · 2024Article
- Automated derivation of diagnostic criteria for lung cancer using natural language processing on electronic health records: a pilot study.BMC medical informatics and decision making · 2024Article
- The incidence of lung cancer amongst primary care chest radiograph referrals-an evaluation of national and local datasets within the United Kingdom.The British journal of radiology · 2024Article
- Current Evidence for a Lung Cancer Screening Program.Portuguese journal of public health · 2024Review
- The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach.NPJ primary care respiratory medicine · 2024Article
- Incidental pulmonary nodule management in Canada: exploring current state through a narrative literature review and expert interviews.Journal of thoracic disease · 2024Review
- The Role of Smoking Status in Making Risk-Informed Diagnostic Decisions in the Lung Cancer Pathway: A Qualitative Study of Health Care Professionals and Patients.Medical decision making : an international journal of the Society for Medical Decision Making · 2024Article
- Efficient lung cancer detection using computational intelligence and ensemble learning.PloS one · 2024Article
- Knowledge-based mechanistic modeling accurately predicts disease progression with gefitinib in EGFR-mutant lung adenocarcinoma.NPJ systems biology and applications · 2023Article
- Review
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Significant advances in the management of both early and advanced stage lung cancer have not yet led to the scale of improved outcomes which have been achieved in other cancers over the last 40 years. Diagnosis of lung cancer at the earliest stage of disease is strongly associated with improved survival. Therefore, although recent advances in oncology may herald breakthroughs in effective treatment, achieving early diagnosis will remain crucial to obtaining optimal outcomes. This is challenging, as most lung cancer symptoms are non-specific or are common respiratory symptoms which usually represent benign disease. Identification of patients at risk of lung cancer who require further investigation is an important responsibility for general practitioners (GPs). Diagnosis has historically relied upon plain chest X-ray (CXR), organised in response to symptoms. The sensitivity of this modality, however, compares unfavourably with that of computed tomography (CT). In some jurisdictions screening high-risk individuals with low dose CT (LDCT) is now recommended. However uptake remains low and the eligibility for screening programmes is restricted. Therefore, even if screening is widely adopted, most patients will continue to be diagnosed after presenting with symptoms. Achieving early diagnosis requires GPs to maintain an appropriate level of suspicion and readiness to investigate in high-risk patients or those with non-resolving symptoms. This article discusses the early detection of lung cancer from a primary care perspective. We outline risk factors and epidemiology, the role of screening and offer guidance on the recognition of symptomatic presentation and the investigation and referral of suspected lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.